NCT07071324 is a NA clinical trial of CF Wellness Program in Cystic Fibrosis (CF), sponsored by Johns Hopkins University.

Who is sponsoring NCT07071324?

NCT07071324 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT07071324?

Interventions in NCT07071324: CF Wellness Program.

What condition does NCT07071324 study?

NCT07071324 studies Cystic Fibrosis (CF), Fatigue, Sleep Quality, Insomnia.

Is NCT07071324 still recruiting?

NCT07071324 is currently recruiting now. Last updated 13 February 2026.

Last reviewed 2026-02-13 · How we verify

NCT07071324

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CF Wellness Program

Recruiting now NA Last updated 13 February 2026

What this trial tests

NA trial testing CF Wellness Program in Cystic Fibrosis (CF) in 80 participants. Currently enrolling.

Timeline

3 February 2026

Primary endpoint
30 June 2028

30 June 2028

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	3 February 2026
Primary completion	30 June 2028
Estimated completion	30 June 2028
Sites	3 locations across United States

Drugs / interventions tested

CF Wellness Program

Conditions studied

Cystic Fibrosis (CF) — all drugs for Cystic Fibrosis (CF) →
Fatigue — all drugs for Fatigue →
Sleep Quality — all drugs for Sleep Quality →
Insomnia — all drugs for Insomnia →

Sponsor

Johns Hopkins University

Who can join

18 and older, any sex, with Cystic Fibrosis (CF) or Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a pilot randomized control trial (RCT; N=80) comparing the Cystic Fibrosis Wellness Program (CFWP) to usual care (UC) to evaluate (1) Intervention Adherence (completion of the CFWP Coaching Sessions) (2) Study Retention (completion of the Week 15 assessment) and (3) Data Quality (valid daytime and nighttime fitness tracker data). A secondary aim is to gather preliminary data to determine if the CFWP has a clinically significant signal over usual care to improve fatigue, sleep, and physical activity (PA) and reduce sedentary behavior.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cystic Fibrosis (CF)

Currently open trials in the same condition.

NCT07303621 — Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population · recruiting
NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
NCT07363304 — Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People Wi · recruiting
NCT07508904 — Exercises' Effect on Muscle Strength, Aerobic Capacity and Respiratory Functions in Cystic Fibrosis · NA · recruiting
NCT07484607 — Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis · recruiting

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07071324 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 13 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07071324.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing